| Clio Foot & Ankle | |
|
2329 Stonebridge Dr Bldg E, Flint, MI 48532-5407 | |
| (810) 230-9955 | |
| Not Available |
| Full Name | Clio Foot & Ankle |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 2329 Stonebridge Dr Bldg E, Flint, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952955601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Rajeev Sehgal |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1184723413 PECOS PAC ID: 3476541947 Enrollment ID: I20040610000263 |
News Archive
The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
› Verified 2 days ago
| Provider Name | Scott Edward Byron |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1780627612 PECOS PAC ID: 7214952423 Enrollment ID: I20051007000102 |
News Archive
The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
› Verified 2 days ago
| Provider Name | Ronald Alan Martin |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1295762888 PECOS PAC ID: 1850302811 Enrollment ID: I20060505000574 |
News Archive
The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
› Verified 2 days ago
| Provider Name | Jessica E Macsuga |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1174941116 PECOS PAC ID: 8224332168 Enrollment ID: I20170707000249 |
News Archive
The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clio Foot & Ankle 2329 Stonebridge Dr Bldg E, Flint, MI 48532-5407 Ph: (810) 230-9955 | Clio Foot & Ankle 2329 Stonebridge Dr Bldg E, Flint, MI 48532-5407 Ph: (810) 230-9955 |
News Archive
The Massachusetts Eye and Ear Infirmary, Harvard Medical School Department of Ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute (NEI), to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.
Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.
Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK.
› Verified 2 days ago
David Wesley Gunsberg, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: G3380 Beecher Rd, Suite A, Flint, MI 48532 Phone: 810-733-3338 Fax: 810-733-7657 | |
Associated Foot Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 915 S Dort Hwy, Flint, MI 48503 Phone: 810-233-5950 | |
Dr. Eugene Thomas Harper, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3725 S Saginaw St, Suite 110, Flint, MI 48507 Phone: 810-238-3338 Fax: 810-238-9577 | |
Rebecca Jolissaint, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2329 Stonebridge Dr Ste E, Flint, MI 48532 Phone: 810-230-9955 | |
Shelby Foot & Ankle Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: G3302 Beecher Rd, Flint, MI 48532 Phone: 810-230-9955 Fax: 810-230-8838 | |
Keith B Daniels Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2811 E Court St, Flint, MI 48506 Phone: 810-424-3338 Fax: 810-424-3226 | |
Dr. Shawn Leslie Reiser, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1303 S Linden Rd, Community Podiatry Group Suite D, Flint, MI 48532 Phone: 215-888-4358 Fax: 810-230-8090 |